查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1225297

流感诊断市场：2023-2028 年全球行业趋势、份额、规模、增长、机遇和预测

Influenza Diagnostics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3个工作天内

价格

到 2022 年，全球流感诊断市场规模将达到 8.934 亿美元。 展望未来，IMARC Group 预计到 2028 年将达到 14.617 亿美元，2023 年至 2028 年的增长率 (CAGR) 为 6.55%。

流感是一种病毒感染，主要影响人类的鼻子、喉咙和肺等呼吸系统。 流感诊断包括许多免疫测定测试，有助于检测呼吸道标本中是否存在甲型和乙型流感核蛋白抗原。 常用的诊断测试包括快速抗原测试、逆转录-聚合□链反应 (RT-PCR)、免疫荧光分析、血清学测试和快速分子分析。 医疗机构可以通过查看其敏感性和特异性来评估这些测试的准确性，这是决定这些测试准确性水平的关键因素。

流感诊断市场趋势

  • 哮喘、慢性阻塞性肺病 (COPD)、支气管扩张和囊性纤维化等几种增加流感风险的慢性病患病率上升，在很大程度上推动了全球流感诊断市场的发展。 此外，易患呼吸道感染的老年人口不断增加也推动了市场增长。 此外，先进诊断免疫测定形式的日益普及以及流感诊断中越来越多地使用小型化仪器也对全球市场产生了积极影响。 此外，引入 CLIA 豁免 POC 分子流感测试以及将消费者偏好从集中式实验室转变为分散式即时检验也推动了市场增长。 此外，快速流感诊断测试 (RIDT) 的日益普及也成为重要的增长动力，这些测试易于使用并可在大约 15 分钟内得出结果。 此外，世卫组织加强流感监测、监测和数据利用的各种举措也推动了市场的增长。 因此，许多政府机构都在积极采取预防措施，以降低流感的风险。 例如，美国疾病预防控制中心和东南亚地区 (SEAR) 合作开展非研究性双边流感支持，以应对禽流感、季节性流感和大流行性流感。 在接下来的几年里，人工智能 (AI) 在流感诊断中的日益整合，以最大限度地缩短样本处理时间并促进无差错结果，预计将推动全球流感诊断市场的发展。

主要市场细分

  • IMARC Group 分析了全球流感诊断市场报告每个子部分的主要趋势，以及 2023 年至 2028 年在全球、区域和国家层面的预测。 该报告根据产品、测试类型、流感类型和最终用户对市场进行分类。

按产品细分

  • 检测试剂盒和试剂
  • 检验设备
  • 其他

按测试类型细分

  • 分子生物学诊断测试
  • 聚合□链反应
  • 等位核酸扩增法
  • 其他分子生物学测试
  • 常规诊断试剂
  • 流感快速诊断测试
  • 病毒培养测试
  • 直接荧光抗体法
  • 血清学检测

按类型划分的流感分类

  • 甲型流感
  • 乙型流感
  • 丙型流感

最终用户细分

  • 医院
  • 诊断机构
  • 其他

按地区划分

  • 北美
  • 美国
  • 加拿大
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • 韩国
  • 澳大利亚
  • 印度尼西亚
  • 其他
  • 欧洲
  • 德国
  • 法国
  • 英国
  • 意大利
  • 西班牙
  • 俄罗斯
  • 其他
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 其他
  • 中东和非洲

内容

第1章前言

第 2 章研究方法和范围

  • 调查的目的
  • 利益相关者
  • 数据来源
    • 主要信息
    • 次要信息
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章执行摘要

第4章介绍

  • 概览
  • 主要行业趋势

第 5 章全球流感诊断市场

  • 市场概览
  • 市场结果
  • COVID-19 的影响
  • 市场预测

第 6 章按产品划分的市场细分

  • 检测试剂盒和试剂
    • 市场趋势
    • 市场预测
  • 乐器
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 7 章按测试类型划分的市场细分

  • 分子生物学诊断剂
    • 市场趋势
    • 主要细分市场
      • 聚合□链反应
      • 等温核酸扩增法
      • 其他分子生物学测试
    • 市场预测
  • 常规诊断试剂
    • 市场趋势
    • 主要细分市场
      • 流感快速诊断试剂
      • 病毒培养测试
      • 直接荧光抗体法
      • 血清学检测
    • 市场预测

第 8 章流感类型市场细分

  • 甲型流感
    • 市场趋势
    • 市场预测
  • 乙型流感
    • 市场趋势
    • 市场预测
  • 丙型流感
    • 市场趋势
    • 市场预测

第 9 章最终用户的市场细分

  • 医院
    • 市场趋势
    • 市场预测
  • 诊断实验室
    • 市场趋势
    • 市场预测
  • 其他
    • 市场趋势
    • 市场预测

第 10 章区域市场细分

  • 北美
    • 美国
      • 市场趋势
      • 市场预测
    • 加拿大
      • 市场趋势
      • 市场展望
  • 亚太地区
    • 中国
      • 市场趋势
      • 市场展望
    • 日本
      • 市场趋势
      • 市场预测
    • 印度
      • 市场趋势
      • 市场展望
    • 韩国市场
      • 市场趋势
      • 市场展望
    • 澳大利亚
      • 市场趋势
      • 市场展望
    • 印度尼西亚
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 欧洲
    • 德国
      • 市场趋势
      • 市场展望
    • 法国
      • 市场趋势
      • 市场预测
    • 英国
      • 市场趋势
      • 市场预测
    • 意大利
      • 市场趋势
      • 市场展望
    • 西班牙
      • 市场趋势
      • 市场展望
    • 俄罗斯
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 拉丁美洲
    • 巴西
      • 市场趋势
      • 市场展望
    • 墨西哥
      • 市场趋势
      • 市场展望
    • 其他
      • 市场趋势
      • 市场预测
  • 中东和非洲
    • 市场趋势
    • 按国家/地区划分的市场细分
    • 市场展望

第 11 章 SWOT 分析

  • 概览
  • 强度
  • 弱点
  • 机会
  • 威胁

第12章价值链分析

第13章搬运工五力分析

  • 概览
  • 买家的议价能力
  • 供应商的议价能力
  • 竞争程度
  • 新进入者的威胁
  • 替代品的威胁

第14章价格分析

第15章竞争格局

  • 市场结构
  • 主要公司
  • 主要公司简介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • Coris Bioconcept
    • Danaher Corporation
    • DiaSorin S.p.A.
    • F. Hoffmann-La Roche Ltd（Roche Holding AG）
    • Hologic Inc.
    • Meridian Bioscience Inc.
    • Qiagen N.V
    • Quidel Corporation
    • Sekisui Diagnostics LLC（Sekisui Medical Co. Ltd.）
    • Siemens Healthineers AG（Siemens AG）
Product Code: SR1423A138_Report

The global influenza diagnostics market size reached US$ 893.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,461.7 Million by 2028, exhibiting a growth rate (CAGR) of 6.55% during 2023-2028.

Influenza, or flu, refers to a viral infection that mainly affects the human respiratory system, including the nose, throat, and lungs. Influenza diagnostics includes numerous immunoassay tests that aid in detecting the presence of influenza A and B viral nucleoprotein antigens in respiratory specimens. Some of the commonly available diagnostic tests include rapid antigen testing, reverse transcription polymerase chain reaction (RT-PCR), immunofluorescence assays, serology, and rapid molecular assays. Healthcare facilities can assess the precision of these tests by looking at their sensitivity and specificity, which are crucial factors that determine their accuracy levels.

Influenza Diagnostics Market Trends:

  • The elevating prevalence of several chronic diseases, such as asthma, chronic obstructive pulmonary disease (COPD), bronchiectasis, cystic fibrosis, etc., that increase the risk of influenza, is primarily driving the global influenza diagnostics market. Besides this, the expanding geriatric population, who are more prone to respiratory tract infections, is also catalyzing the market growth. Additionally, the rising availability of advanced diagnostic immunoassay formats along with the growing usage of miniaturized devices in influenza diagnostics is positively influencing the global market. Moreover, the introduction of CLIA-waived POC molecular influenza tests and the shifting consumer preferences from centralized laboratories to decentralized point-of-care testing are also augmenting the market growth. In addition to this, the emerging popularity of rapid influenza diagnostic test (RIDT) that are convenient to use and provide results in approximately fifteen minutes is acting as a significant growth-inducing factor. Furthermore, various initiatives by WHO to strengthen influenza surveillance, monitoring, and data utilization, are also stimulating the market growth. In line with this, numerous government bodies are becoming more actively involved in taking preventative steps to reduce the risk of influenza. For instance, the U.S. CDC and the South-East Asian Region (SEAR) have collaborated to support non-researched bilateral influenza as a response to avian, seasonal, and pandemic influenza. In the coming years, the growing integration of artificial intelligence (AI) in influenza diagnostics to minimize the timelines for sample processing and facilitate error-free results is expected to drive the global influenza diagnostics market.

Key Market Segmentation:

  • IMARC Group provides an analysis of the key trends in each sub-segment of the global influenza diagnostics market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, test type, type of flu and end user.

Breakup by Product:

  • Test Kit and Reagents
  • Instruments
  • Others

Breakup by Test Type:

  • Molecular Diagnostic Tests
  • Polymerase Chain Reaction
  • Isothermal Nucleic Acid Amplification Tests
  • Other Molecular Tests
  • Traditional Diagnostic Tests
  • Rapid Influenza Diagnostic Tests
  • Viral Culture Tests
  • Direct Fluorescent Antibody Test
  • Serological Tests

Breakup by Type of Flu:

  • Type A Flu
  • Type B Flu
  • Type C Flu

Breakup by End User:

  • Hospitals
  • Diagnostic Laboratories
  • Others

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

Competitive Landscape:

  • The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, Coris Bioconcept, Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd (Roche Holding AG), Hologic Inc., Meridian Bioscience Inc., Qiagen N.V, Quidel Corporation, Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.) and Siemens Healthineers AG (Siemens AG).
  • Key Questions Answered in This Report
  • 1. What was the size of the global influenza diagnostics market in 2022?
  • 2. What is the expected growth rate of the global influenza diagnostics market during 2023-2028?
  • 3. What are the key factors driving the global influenza diagnostics market?
  • 4. What has been the impact of COVID-19 on the global influenza diagnostics market?
  • 5. What is the breakup of the global influenza diagnostics market based on the product?
  • 6. What is the breakup of the global influenza diagnostics market based on the test type?
  • 7. What is the breakup of the global influenza diagnostics market based on type of flu?
  • 8. What is the breakup of the global influenza diagnostics market based on the end user?
  • 9. What are the key regions in the global influenza diagnostics market?
  • 10. Who are the key players/companies in the global influenza diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Influenza Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Test Kit and Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Others
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Test Type

  • 7.1 Molecular Diagnostic Tests
    • 7.1.1 Market Trends
    • 7.1.2 Key Segments
      • 7.1.2.1 Polymerase Chain Reaction
      • 7.1.2.2 Isothermal Nucleic Acid Amplification Tests
      • 7.1.2.3 Other Molecular Tests
    • 7.1.3 Market Forecast
  • 7.2 Traditional Diagnostic Tests
    • 7.2.1 Market Trends
    • 7.2.2 Key Segments
      • 7.2.2.1 Rapid Influenza Diagnostic Tests
      • 7.2.2.2 Viral Culture Tests
      • 7.2.2.3 Direct Fluorescent Antibody Test
      • 7.2.2.4 Serological Tests
    • 7.2.3 Market Forecast

8 Market Breakup by Type of Flu

  • 8.1 Type A Flu
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Type B Flu
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Type C Flu
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by End User

  • 9.1 Hospitals
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Diagnostic Laboratories
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Becton Dickinson and Company
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Coris Bioconcept
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Danaher Corporation
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
      • 15.3.4.4 SWOT Analysis
    • 15.3.5 DiaSorin S.p.A.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 SWOT Analysis
    • 15.3.7 Hologic Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Meridian Bioscience Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Qiagen N.V
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Quidel Corporation
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Sekisui Diagnostics LLC (Sekisui Medical Co. Ltd.)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 Siemens Healthineers AG (Siemens AG)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Influenza Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Influenza Diagnostics Market: Sales Value (in Million US$), 2017-2022
  • Figure 3: Global: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 4: Global: Influenza Diagnostics Market: Breakup by Product (in %), 2022
  • Figure 5: Global: Influenza Diagnostics Market: Breakup by Test Type (in %), 2022
  • Figure 6: Global: Influenza Diagnostics Market: Breakup by Type of Flu (in %), 2022
  • Figure 7: Global: Influenza Diagnostics Market: Breakup by End User (in %), 2022
  • Figure 8: Global: Influenza Diagnostics Market: Breakup by Region (in %), 2022
  • Figure 9: Global: Influenza Diagnostics (Test Kit and Reagents) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 10: Global: Influenza Diagnostics (Test Kit and Reagents) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 11: Global: Influenza Diagnostics (Instruments) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 12: Global: Influenza Diagnostics (Instruments) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 13: Global: Influenza Diagnostics (Other Products) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 14: Global: Influenza Diagnostics (Other Products) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 15: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 16: Global: Influenza Diagnostics (Molecular Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 17: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 18: Global: Influenza Diagnostics (Traditional Diagnostic Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 19: Global: Influenza Diagnostics (Type A Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 20: Global: Influenza Diagnostics (Type A Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 21: Global: Influenza Diagnostics (Type B Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 22: Global: Influenza Diagnostics (Type B Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 23: Global: Influenza Diagnostics (Type C Flu) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 24: Global: Influenza Diagnostics (Type C Flu) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 25: Global: Influenza Diagnostics (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 26: Global: Influenza Diagnostics (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 27: Global: Influenza Diagnostics (Diagnostic Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 28: Global: Influenza Diagnostics (Diagnostic Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 29: Global: Influenza Diagnostics (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 30: Global: Influenza Diagnostics (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 31: North America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 32: North America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 33: United States: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 34: United States: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 35: Canada: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 36: Canada: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 37: Asia-Pacific: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 38: Asia-Pacific: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 39: China: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 40: China: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 41: Japan: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 42: Japan: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 43: India: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 44: India: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 45: South Korea: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 46: South Korea: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 47: Australia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 48: Australia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 49: Indonesia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 50: Indonesia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 51: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 52: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 53: Europe: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 54: Europe: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 55: Germany: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 56: Germany: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 57: France: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 58: France: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 59: United Kingdom: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 60: United Kingdom: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 61: Italy: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 62: Italy: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 63: Spain: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 64: Spain: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 65: Russia: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 66: Russia: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 67: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 68: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 69: Latin America: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 70: Latin America: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 71: Brazil: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 72: Brazil: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 73: Mexico: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 74: Mexico: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 75: Others: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 76: Others: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 77: Middle East and Africa: Influenza Diagnostics Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 78: Middle East and Africa: Influenza Diagnostics Market: Breakup by Country (in %), 2022
  • Figure 79: Middle East and Africa: Influenza Diagnostics Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Global: Influenza Diagnostics Industry: SWOT Analysis
  • Figure 81: Global: Influenza Diagnostics Industry: Value Chain Analysis
  • Figure 82: Global: Influenza Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Influenza Diagnostics Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Influenza Diagnostics Market Forecast: Breakup by Product (in Million US$), 2023-2028
  • Table 3: Global: Influenza Diagnostics Market Forecast: Breakup by Test Type (in Million US$), 2023-2028
  • Table 4: Global: Influenza Diagnostics Market Forecast: Breakup by Type of Flu (in Million US$), 2023-2028
  • Table 5: Global: Influenza Diagnostics Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 6: Global: Influenza Diagnostics Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 7: Global: Influenza Diagnostics Market: Competitive Structure
  • Table 8: Global: Influenza Diagnostics Market: Key Players